Troubles du rythme supra-ventriculaires

Description

01/01/2003

Informations

• Publié par: sfcardio
• Publié le: 01 janvier 2003
• Nombre de lectures: 55
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: Français

Extrait

© 2003 by the American College of Cardiology Foundation, the American Heart Association, Inc., and the European Society of Cardiology
ACC/AHA/ESC PRACTICE GUIDELINES—FULL TEXT
ACC/AHA/ESC Guidelines for the Management of Patients
With Supraventricular Arrhythmias*
A Report of the American College of Cardiology/American Heart Association Task Force
and the European Society of Cardiology Committee for Practice Guidelines (Writing
Committee to Develop Guidelines for the Management of Patients With Supraventricular
Arrhythmias)
Developed in Collaboration with NASPE-Heart Rhythm Society
COMMITTEE MEMBERS
Carina Blomström-Lundqvist, MD, PhD, FACC, FESC, Co-Chair
Melvin M. Scheinman, MD, FACC, Co-Chair
Etienne M. Aliot, MD, FACC, FESC Karl H. Kuck, MD, FACC, FESC
Joseph S. Alpert, MD, FACC, FAHA, FESC Bruce B. Lerman, MD, FACC
Hugh Calkins, MD, FACC, FAHA D. Douglas Miller, MD, CM, FACC
A. John Camm, MD, FACC, FAHA, FESC Charlie Willard Shaeffer, Jr., MD, FACC
W. Barton Campbell, MD, FACC, FAHA William G. Stevenson, MD, FACC
David E. Haines, MD, FACC Gordon F. Tomaselli, MD, FACC, FAHA
TASK FORCE MEMBERS
Elliott M. Antman, MD, FACC, FAHA, Chair
Sidney C. Smith, Jr., MD, FACC, FAHA, FESC, Vice Chair
Joseph S. Alpert, MD, FACC, FAHA, FESC Gabriel Gregoratos, MD, FACC, FAHA
David P. Faxon, MD, FACC, FAHA Loren F. Hiratzka, MD, FACC, FAHA
Valentin Fuster, MD, PhD, FACC, FAHA, FESC Sharon Ann Hunt, MD, FACC, FAHA
Raymond J. Gibbons, MD, FACC, FAHA†‡ Alice K. Jacobs, MD, FACC, FAHA
Richard O. Russell, Jr., MD, FACC, FAHA†
ESC COMMITTEE FOR PRACTICE GUIDELINES MEMBERS
Silvia G. Priori, MD, PhD, FESC, Chair
Jean-Jacques Blanc, MD, PhD, FESC John Lekakis, MD, FESC
Andzrej Budaj, MD, FESC Bertil Lindahl, MD
Enrique Fernandez Burgos, MD Gianfranco Mazzotta, MD, FESC
Martin Cowie, MD, PhD, FESC João Carlos Araujo Morais, MD, FESC
Jaap Willem Deckers, MD, PhD, FESC Ali Oto, MD, FACC, FESC
Maria Angeles Alonso Garcia, MD, FESC Otto Smiseth, MD, PhD, FESC
Werner W. Klein, MD, FACC, FESC‡ Hans-Joachim Trappe, MD, PhD, FESC
*This document does not cover atrial fibrillation, which is covered in the Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB,
ACC/AHA/ESC guidelines on the management of patients with atrial fibrilla- Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG,
tion found on the ACC, AHA, and ESC Web sites. Tomaselli GF. ACC/AHA/ESC guidelines for the management of patients with
†Former Task Force Member supraventricular arrhythmias: a report of the American College of
‡Immediate Past Chair Cardiology/American Heart Association Task Force on Practice Guidelines and
the European Society of Cardiology Committee for Practice Guidelines
(Writing Committee to Develop Guidelines for the Management of Patients
This document was approved by the American College of Cardiology With Supraventricular Arrhythmias. 2003. American College of Cardiology
Foundation Board of Trustees in August 2003, by the American Heart Web Site. Available at: http://www.acc.org/clinical/guidelines/arrhythmias/
Association Science Advisory and Coordinating Committee in July 2003, and sva_index.pdf.
by the European Society of Cardiology Committee for Practice Guidelines in This document is available on the World Wide Web sites of the American
July 2003. College of Cardiology (www.acc.org), the American Heart Association
When citing this document, the American College of Cardiology Foundation, (www.americanheart.org), and the European Society of Cardiology
the American Heart Association, and the European Society of Cardiology (www.escardio.org). Single and bulk reprints of both the online full-text guide-
request that the following citation format be used: Blomström-Lundqvist C, lines and the published executive summary (published in the October 15, 2003ACC - www.acc.org
Blomström-Lundqvist and Scheinman et al. 2003 AHA - www.americanheart.org
2 ACC/AHA/ESC Practice Guidelines ESC - www.escardio.org
issue of the Journal of the American College of Cardiology, the October 14, 6. Summary of Management........................................28
2003 issue of Circulation, and the 24/20, October 15, 2003, issue of the E. Focal Atrial Tachycardias.............................................29
European Heart Journal) are available from Elsevier Publishers by calling 1. Definition and Clinical Presentation........................29
+44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing to 2. Diagnosis..................................................................29
Elsevier Publishers Ltd, European Heart Journal, ESC Guidelines - Reprints, 32
3. Site of Origin and Mechanisms...............................31
Jamestown Road, London, NW1 7BY, UK or E-mail [e-mail].
4. Treatment.................................................................31Single copies of the executive summary and the full-text guidelines are also
5. Multifocal Atrial Tachycardia.................................33available by calling 800-253-4636 or writing the American College of
F. Macro–Re-entrant Atrial Tachycardia..........................33Cardiology Foundation, Resource Center, at 9111 Old Georgetown Road,
1. Isthmus-Dependent Atrial Flutter............................33Bethesda, MD 20814-1699. To purchase bulk reprints (specify version and
reprint number-executive summary 71-0261 and full-text guideline 71-0262): up 2. Non–Cavotricuspid Isthmus-Dependent Atrial
to 999 copies, call 800-611-6083 (U.S. only) or fax [phone]; 1 000 or Flutter ......................................................................38
more copies, call 214-706-1466, fax [phone]; or E-mail
VI. Special Circumstance[e-mail].
A. Pregnancy.....................................................................39
1. Acute Conversion of Atrioventricular Node–
TABLE OF CONTENTS Dependent Tachycardias...........................................40
2. Prophylactic Antiarrhythmic Drug Therapy............40
Preamble ................................................................................... 2 B. Supraventricular Tachycardias in Adult Patients With
Congenital Heart Disease.............................................41I. Introduction........................................................................ 3
1. Introduction..............................................................41A. Organization of Committee and Evidence Review........3
2. Specific Disorders....................................................41B. Contents of These Guidelines—Scope..........................4
C. Drug-Drug and Drug-Metabolic Interactions..............43
II. Public Health Considerations and Epidemiology..............4 D. Quality-of-Life and Cost Considerations....................44
III. General Mechanisms of Supraventricular Arrhythmia......5 Appendix 1: Abbreviations......................................................46
A. Specialized Atrial Tissue...............................................5
Appendix 2: Peer Reviewers....................................................47B. General Mechanisms.....................................................6
IV. Clinical Presentation, General Evaluation, and References................................................................................48
Management of Patients With Supraventricular
Arrhythmia .......................................................................7
A. General Evaluation of Patients Without Documented PREAMBLE
Arrhythmia.....................................................................7
1. Clinical History and Physical Examination...............7 It is important that the medical profession play a significant
2. Diagnostic Investigations...........................................8 role in critically evaluating the use of diagnostic procedures
3. Management...............................................................9 and therapies in the management or prevention of disease
B. General Evaluation of Patients With Documented
states. Rigorous and expert analysis of the available data doc-
Arrhythmia.....................................................................9
umenting relative benefits and risks of those procedures and
1. Diagnostic Evaluation................................................9
therapies can produce helpful guidelines that improve the2. Management.............................................................12
effectiveness of care, optimize patient outcomes, and gener-
V. Specific Arrhythmias.......................................................14 ally have a favorable effect on the overall cost of care by
A. Sinus Tachyarrhythmias..............................................14 focusing resources on the most effective strategies.
1. Physiological Sinus Tachycardia.............................14 The American College of Cardiology Foundation (ACCF),
2. Inappropriate Sinus Tachycardia.............................16
the American Heart Association (AHA) have jointly engaged
3. Postural Orthostatic Tachycardia Syndrome...........17
in the production of such guidelines in the area of cardiovas-
4. Sinus Node Re-entry Tachycardia...........................19
cular disease since 1980. The ACC/AHA Task Force onB. Atrioventricular Nodal Reciprocating Tachycardia.....20
Practice Guidelines, whose charge is to develop and revise1. Definitions and Clinical Features............